Compile Data Set for Download or QSAR
Report error Found 119 Enz. Inhib. hit(s) with all data for entry = 7973
LigandPNGBDBM226282(US9321790, 94)
Affinity DataIC50: 130nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226283(US9321790, 95)
Affinity DataIC50: 180nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226271(US9321790, 83)
Affinity DataIC50: 190nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226272(US9321790, 84)
Affinity DataIC50: 200nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226266(US9321790, 78)
Affinity DataIC50: 250nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226299(US9321790, 111)
Affinity DataIC50: 330nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226270(US9321790, 82)
Affinity DataIC50: 340nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226305(US9321790, 117)
Affinity DataIC50: 380nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226285(US9321790, 97)
Affinity DataIC50: 440nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226280(US9321790, 92)
Affinity DataIC50: 450nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226289(US9321790, 101)
Affinity DataIC50: 450nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226303(US9321790, 115)
Affinity DataIC50: 590nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226260(US9321790, 72)
Affinity DataIC50: 730nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226281(US9321790, 93)
Affinity DataIC50: 780nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226259(US9321790, 71)
Affinity DataIC50: 810nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226262(US9321790, 74)
Affinity DataIC50: 820nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226265(US9321790, 77)
Affinity DataIC50: 820nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226291(US9321790, 103)
Affinity DataIC50: 840nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226292(US9321790, 104)
Affinity DataIC50: 930nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226264(US9321790, 76)
Affinity DataIC50: 950nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226213(US9321790, 25)
Affinity DataIC50: 1.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226258(US9321790, 70)
Affinity DataIC50: 1.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226211(US9321790, 23)
Affinity DataIC50: 1.04E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226276(US9321790, 88)
Affinity DataIC50: 1.30E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226215(US9321790, 27)
Affinity DataIC50: 1.53E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226267(US9321790, 79)
Affinity DataIC50: 1.60E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226268(US9321790, 80)
Affinity DataIC50: 1.60E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226293(US9321790, 105)
Affinity DataIC50: 1.90E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226288(US9321790, 100)
Affinity DataIC50: 1.98E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226214(US9321790, 26)
Affinity DataIC50: 2.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226269(US9321790, 81)
Affinity DataIC50: 2.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226242(US9321790, 54)
Affinity DataIC50: 2.21E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226216(US9321790, 28)
Affinity DataIC50: 2.26E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226278(US9321790, 90)
Affinity DataIC50: 2.40E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226212(US9321790, 24)
Affinity DataIC50: 2.44E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226261(US9321790, 73)
Affinity DataIC50: 2.50E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226290(US9321790, 102)
Affinity DataIC50: 2.50E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226237(US9321790, 49)
Affinity DataIC50: 2.74E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226277(US9321790, 89)
Affinity DataIC50: 2.80E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226200(US9321790, 12)
Affinity DataIC50: 2.90E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226189(US9321790, 1)
Affinity DataIC50: 3.13E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226220(US9321790, 32)
Affinity DataIC50: 3.70E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226255(US9321790, 67)
Affinity DataIC50: 4.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226229(US9321790, 41)
Affinity DataIC50: 4.20E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226238(US9321790, 50)
Affinity DataIC50: 4.30E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226201(US9321790, 13)
Affinity DataIC50: 5.75E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226226(US9321790, 38)
Affinity DataIC50: 5.77E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226219(US9321790, 31)
Affinity DataIC50: 6.35E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226246(US9321790, 58)
Affinity DataIC50: 6.40E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

LigandPNGBDBM226256(US9321790, 68)
Affinity DataIC50: 6.60E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 119 total ) | Next | Last >>
Jump to: